Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1999 1
2004 5
2005 1
2007 2
2008 2
2009 1
2010 8
2011 3
2013 5
2014 3
2015 7
2016 8
2017 1
2018 6
2019 3
2020 5
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.
Update on facial aging.
Fitzgerald R, Graivier MH, Kane M, Lorenc ZP, Vleggaar D, Werschler WP, Kenkel JM. Fitzgerald R, et al. Among authors: werschler wp. Aesthet Surg J. 2010 Jul-Aug;30 Suppl:11S-24S. doi: 10.1177/1090820X10378696. Aesthet Surg J. 2010. PMID: 20844296 Review.
Facial aesthetic analysis.
Fitzgerald R, Graivier MH, Kane M, Lorenc ZP, Vleggaar D, Werschler WP, Kenkel JM. Fitzgerald R, et al. Among authors: werschler wp. Aesthet Surg J. 2010 Jul-Aug;30 Suppl:25S-7S. doi: 10.1177/1090820X10373360. Aesthet Surg J. 2010. PMID: 20844297
Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study.
Eichenfield LF, Stein Gold L, Kircik LH, Werschler WP, Beer K, Draelos ZD, Tanghetti EA, Papp KA, Baldwin H, Lain E, Sadick N, Gooderham MJ, Konda A. Eichenfield LF, et al. Among authors: werschler wp. Pediatr Dermatol. 2023 May-Jun;40(3):452-459. doi: 10.1111/pde.15283. Epub 2023 Mar 22. Pediatr Dermatol. 2023. PMID: 36949579 Clinical Trial.
Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials.
Stein Gold L, Lain E, Del Rosso JQ, Gold M, Draelos ZD, Eichenfield LF, Sadick N, Werschler WP, Gooderham MJ, Lupo M. Stein Gold L, et al. Among authors: werschler wp. J Am Acad Dermatol. 2023 Nov;89(5):927-935. doi: 10.1016/j.jaad.2022.08.069. Epub 2023 Sep 1. J Am Acad Dermatol. 2023. PMID: 37656094 Free article.
Surgical versus nonsurgical rejuvenation.
Fitzgerald R, Graivier MH, Kane M, Lorenc ZP, Vleggaar D, Werschler WP, Kenkel JM. Fitzgerald R, et al. Among authors: werschler wp. Aesthet Surg J. 2010 Jul-Aug;30 Suppl:28S-30S. doi: 10.1177/1090820X10373365. Aesthet Surg J. 2010. PMID: 20844298
66 results